Fda advisory committee votes in favor of granting emergency use authorization for the pfizer-biontech covid-19 vaccine in children 5 to

New york and mainz, germany, october 26, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration's (fda) vaccines and related biological products advisory committee (vrbpac) voted 17 to 0, with 1 abstention, to recommend that the fda grant emergency use authorization (eua) for the companies' covid-19 vaccine in children 5 to
BNTX Ratings Summary
BNTX Quant Ranking